Research Advances and Application Progress on miRNAs in Exosomes Derived From M2 Macrophage for Tissue Injury

Zhikang Zhu1, Xinge Zhang1, Xuran Lin1

  • 1Department of Plastic Surgery, The Fourth Affiliated Hospital of School of Medicine, and International School of Medicine, Zhejiang University, Yiwu, Zhejiang, People's Republic of China.

PubMed

Insights

M2 macrophage-derived exosomes (M2-Exos) carrying microRNAs (miRNAs) are key to tissue repair. This review details their functions and therapeutic potential in healing various injuries.

Area of Science:

  • Regenerative Medicine
  • Cell Biology
  • Immunology

Background:

  • Tissue repair involves complex immune cell interactions, with M2 macrophages playing a vital role.
  • M2 macrophage-derived exosomes (M2-Exos) mediate intercellular communication via microRNAs (miRNAs), influencing tissue regeneration.
  • Understanding these mechanisms is crucial for developing regenerative therapies.

Purpose of the Study:

  • To review exosome biogenesis, miRNA synthesis and function, and exosome extraction methods.
  • To summarize the diverse functions and mechanisms of M2-Exos miRNAs in tissue repair across various biological systems.
  • To explore the potential applications of M2-Exos in disease prevention, diagnosis, and clinical practice.

Main Methods:

  • Literature review of exosome biology and miRNA functions.
  • Analysis of studies on M2-Exos in different tissue repair models.
  • Synthesis of current research on therapeutic applications and challenges.

Main Results:

  • M2-Exos deliver specific miRNAs that modulate cellular processes essential for tissue repair.
  • These exosomes have demonstrated efficacy in promoting healing in various injury models.
  • Identified key miRNAs and their targets involved in M2-Exo-mediated repair.

Conclusions:

  • M2-Exos represent a promising cell-free therapeutic strategy for tissue injury repair.
  • Further research is needed to optimize exosome extraction and clinical application efficiency and safety.
  • The therapeutic potential of M2-Exos in regenerative medicine is significant but requires further validation.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.1K
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.6K